Limits to Personalized Cancer Medicine.
From the Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, Toronto (I.F.T.); and AGON-Paris, Paris (J.A.H.).
Ian F
IF
Tannock
From the Division of Medical Oncology, Princess Margaret Cancer Centre and the University of Toronto, Toronto (I.F.T.); and AGON-Paris, Paris (J.A.H.).
John A
JA
Hickman
D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use*; D016527:Drug Costs; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D005380:Financing, Government; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000628:therapy*; D057285:Precision Medicine / Q000191:economics
D000970:Antineoplastic Agents